Oxcarbazepine 600 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the comparative bioavailability between
Oxcarbazepine 600 mg Tablets (test) and Trileptal® 600 mg Tablets (reference) after a
single-dose in healthy subjects under fasting conditions.